Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:45 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC0
0%
-2,583,821decrease
(Position Closed)
View
2023-02-14
4:14 pm
Sale
13GCybin Inc.
CYBN
ORBIMED CAPITAL LLC6,153,299
3.7%
-5,138,001decrease
(-45.50%)
View
2022-02-11
4:44 pm
Purchase
13GSI-BONE, Inc.
SIBN
ORBIMED CAPITAL LLC2,305,300
6.9%
2,305,300increase
(New Position)
View
2022-02-11
4:32 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC2,583,821
8.7%
90,712increase
(+3.64%)
View
2022-02-11
4:20 pm
Purchase
13GCybin Inc.
CYBN
ORBIMED CAPITAL LLC11,291,300
7%
11,291,300increase
(New Position)
View
2022-02-11
4:15 pm
Sale
13GAptose Biosciences Inc.
APTO
ORBIMED CAPITAL LLC0
0%
-8,030,000decrease
(Position Closed)
View
2021-02-12
5:03 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC2,493,109
8.36%
2,493,109increase
(New Position)
View
2021-02-12
4:42 pm
Purchase
13GAptose Biosciences Inc.
APTO
ORBIMED CAPITAL LLC8,030,000
9.04%
8,030,000increase
(New Position)
View
2020-02-14
12:00 pm
Sale
13GFoamix Pharmaceuticals Ltd.
FOMX
ORBIMED CAPITAL LLC2,577,982
4.17%
-2,617,348decrease
(-50.38%)
View
2019-02-12
5:53 pm
Purchase
13GFoamix Pharmaceuticals Ltd.
FOMX
ORBIMED CAPITAL LLC5,195,330
9.57%
5,195,330increase
(New Position)
View